Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-10
2005-05-10
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S328000, C514S423000, C546S221000, C546S226000, C548S539000
Reexamination Certificate
active
06890939
ABSTRACT:
The present invention is directed to compounds useful as selective serine protease or dual-serine protease inhibitors, compositions thereof and methods for treating serine protease or dual-serine protease mediated disorders.
REFERENCES:
patent: 5607937 (1997-03-01), Stuerzebecher et al.
patent: 5612353 (1997-03-01), Ewing et al.
patent: 5747535 (1998-05-01), Oh et al.
patent: 5770600 (1998-06-01), Abelman et al.
patent: 5869501 (1999-02-01), Hirayama et al.
patent: 5935959 (1999-08-01), Inoue et al.
patent: 0 203 743 (1986-12-01), None
patent: 0 299 493 (1989-01-01), None
patent: 0 623595 (1994-11-01), None
patent: 0 739 886 (1996-10-01), None
patent: WO 9605189 (1996-02-01), None
patent: WO 9610022 (1996-04-01), None
patent: WO 9616940 (1996-06-01), None
patent: WO 9640679 (1996-12-01), None
patent: WO 9640737 (1996-12-01), None
patent: WO 9719919 (1997-06-01), None
patent: WO 9740023 (1997-10-01), None
patent: WO 9805336 (1998-02-01), None
patent: WO 9854164 (1998-12-01), None
patent: WO 98 57934 (1998-12-01), None
Kaiser, Brigitte, Thrombin and Factor Xa Inhibitors,Drugs of the Future, 1998, 23(4), 423-436.
Kunitada, S., et al., Factor Xa Inhibitors,Current Pharmaceutical Design, 1996, 2, 531-542.
Drugs of the Future1999, 24(7), 771-787.
Ermolieff, J., et al, Proteolytic Activation of Recombinant Pro-memapsin 2 (Pro-□-secretase) Studied with New Fluorogenic Substrates,Biochemistry, 2000, 39,12450-12456.
Syn. Comm. 1992, 22(19) 2357.
Syn. Comm. 1993, 23(10), 1443.
Boyd Robert E.
Greco Michael N.
Hawkins Michael J.
Maryanoff Bruce E.
McKane Joseph K.
Ortho-McNeil Pharmaceutical , Inc.
Small Andrea D.
LandOfFree
Aminopyrrolidine sulfonamides as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminopyrrolidine sulfonamides as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopyrrolidine sulfonamides as serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3422458